EGFR signaling in breast cancer: Bad to the bone
- 31 December 2010
- journal article
- review article
- Published by Elsevier BV in Seminars in Cell & Developmental Biology
- Vol. 21 (9), 951-960
- https://doi.org/10.1016/j.semcdb.2010.08.009
Abstract
No abstract availableKeywords
This publication has 125 references indexed in Scilit:
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival SignalsCancer Cell, 2009
- Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loopCellular Signalling, 2009
- Invasive ductal carcinoma of the breast with the “triple-negative” phenotype: prognostic implications of EGFR immunoreactivityBreast Cancer Research and Treatment, 2008
- HER4 Intracellular Domain (4ICD) Activity in the Developing Mammary Gland and Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2008
- Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrantBreast Cancer Research and Treatment, 2008
- The epidermal growth factor receptor family: Biology driving targeted therapeuticsCellular and Molecular Life Sciences, 2008
- Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cellsBreast Cancer Research and Treatment, 2007
- Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesisBioEssays, 2007
- A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesCancer Cell, 2006